SFTPA2 and adenocarcinoma: Moreover, Grageda et al. [51] found lower SFTPA2 mRNA/protein expression in pulmonary squamous-cell carcinoma and adenocarcinoma, accompanied by higher DNA methylation of the gene promoter in the former.